Documentos relacionados

1. [Risk of infections associated with the use of biological medications; a review].
2. Does perioperative biological therapy increase 30-day post-operative complication rates in inflammatory bowel disease patients undergoing intra-abdominal surgery? A systematic review.
3. Comorbidity Influences the Comparative Safety of Biologic Therapy in Older Adults With Inflammatory Bowel Diseases.
4. Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease.
5. Active pharmacovigilance program in patients affected by psoriasis and inflammatory bowel diseases
.
6. Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel Disease.
7. [Biological therapy in inflammatory bowel disease pregnant patients: An expanded view on its use].
8. Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD.
9. A systematic monitoring approach to biologic therapies in inflammatory bowel disease: patients' and physicians' preferences and adherence.
10. Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD.